No — semaglutide is not the same as Saxenda. They belong to the same GLP-1 family and both support medical weight loss, but they use different active ingredients, are dosed differently, and patients often respond differently to each. At Nusbaum Medical Centers in Cedar Knolls, NJ, Michael Nusbaum, MD FACS · FASMBS, prescribes GLP-1 therapy as a medical tool matched to your profile — not a name you recognized online. Understanding what actually separates these two medications is the first step to choosing the one that fits your goals and tolerance.
The Short Answer: No, They're Different Medications
If you are comparing injectable weight-loss options and asking whether semaglutide is the same as Saxenda, the direct answer is no. Saxenda is the brand name for liraglutide, a GLP-1 receptor agonist approved for chronic weight management. Semaglutide is a different GLP-1 receptor agonist — a distinct molecule with a longer duration of action.
This is where many patients get confused. They hear that both are GLP-1 medications, both are injections, and both are used for weight loss, so they assume the two are essentially interchangeable. Clinically, that's too simplistic. Belonging to the same category does not mean being the same treatment, and the two are not interchangeable without medical guidance. You can learn more about our approach on the semaglutide weight loss page.
How Semaglutide and Saxenda Work
Both medications mimic GLP-1, a hormone your gut releases after eating that influences appetite, gastric emptying, and blood sugar. In practical terms, that can mean you feel full sooner, stay full longer, and experience fewer cravings — the kind of consistency that traditional diet plans often can't sustain.
That shared mechanism is why both can help patients who have cycled through diets and short-term fixes for years. But the way each molecule behaves in the body differs meaningfully, and those differences shape convenience, tolerability, and results. According to the U.S. Food and Drug Administration, these are prescription medications indicated for specific patient profiles — which is exactly why physician supervision matters as part of a structured medical weight loss program.
The Key Differences That Matter
The distinctions between these two medications are practical, not academic — they affect your daily routine and your outcome.
- Active ingredient: Saxenda contains liraglutide; semaglutide is a separate compound.
- Dosing frequency: Saxenda is injected daily. Semaglutide's longer duration of action allows once-weekly dosing.
- Adherence and treatment fatigue: a weekly injection reduces the daily reminder of treatment for many patients, while others prefer the routine of a daily dose.
- Average results: in clinical studies, semaglutide has frequently produced greater average weight loss, though individual response varies.
None of these differences make one universally "better." They make one potentially better for you. Some patients also do best on a different GLP-1 entirely, such as tirzepatide, which acts on two hormone pathways.
Choosing the Right Medication for You
The best medication isn't the one you've heard of most — it's the one matched to your medical profile, your goals, your tolerance for side effects, and the level of supervision behind the plan. That's a clinical decision, made with a physician, not a self-diagnosis from a search bar.
At Nusbaum Medical Centers, a GLP-1 prescription starts with an evaluation of your health history, current medications, and metabolic markers. From there, the choice between semaglutide, liraglutide (Saxenda), or tirzepatide is individualized — and the dose is escalated gradually to minimize side effects. If a non-medication path fits better, we'll tell you that too. Explore your options across our medical weight loss and surgical weight loss programs, or read more in The Nusbaum Journal.
